What age is Vigamox indicated for?

Vigamox, which contains moxifloxacin, is an ophthalmic solution used to treat bacterial conjunctivitis. The indication for use is an essential aspect of prescribing this medication safely and effectively.

Moxifloxacin's development and clinical trials have established its safety and efficacy in pediatric patients aged 1 year and older. Therefore, this age guideline reflects both the ability of children in this age group to receive the medication and the documented supportive clinical findings to back its use in this population.

This means that children starting from 1 year of age can be prescribed Vigamox for the treatment of bacterial conjunctivitis, as they can typically cooperate with the application of eye drops and have a lower likelihood of adverse reactions than very young infants. The documentation on its use in patients younger than this age supports the decision to specify an age starting at 1 year for both safety and dosing purposes.